Xyratex Falls 11% After Q1 Results - XORTX Therapeutics (NASDAQ:XRTX)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Xyratex (NASDAQ: XRTX) released its fiscal Q1 earnings results after the closing bell on Thursday. The company reported EPS of $0.38 versus $0.15 in the year ago period. This compared to consensus EPS estimates of $0.26. Revenues for the quarter were $293.7 million versus Street estimates of $316.51 million. The company guided fiscal Q2 EPS and revenues in line with Street estimates. In Thursday's after hours trading session, XRTX shares have lost 11.34% to $15.80 as investors react to the Q1 revenue miss.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!